Rapid Dose Therapeutics Signs Agreement with AB Strategic Ventures for Business Development Advisory Services with First Nations Enterprises
BURLINGTON, Ontario–(BUSINESS WIRE)–Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, has entered into a strategic business development agreement with AB Strategic Ventures (“ABSV”) with the purpose of supporting relationship building with First Nations business enterprises through the fulfillment... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )